Sanofi (SAN) | Stock Overview & Key Data
Sanofi Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €110.88 on March 10, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sanofi SAN | N/A | 4.70% | 6.28% | -6.70% | -15.99% | -7.26% | -12.83% | 6.81% | 2.87% |
| Virbac S.A VIRP | 2.86B Large-cap | 3.18% | -2.71% | 9.29% | 9.47% | 6.90% | -0.29% | -8.70% | 81.77% |
| EssilorLuxottica EL | 123.50B Large-cap | 3.38% | 11.70% | 4.45% | -6.50% | 16.14% | 26.57% | 79.07% | 139.75% |
| Sartorius Stedim DIM | 17.27B Large-cap | -0.40% | -7.43% | -11.07% | -13.75% | -4.75% | -0.65% | -53.41% | -40.52% |
| bioMérieux S.A BIM | 14.97B Large-cap | 0.71% | 7.60% | 6.97% | 13.24% | 24.05% | 23.21% | 21.51% | 1.92% |
| Eurofins Scientific ERF | 11.97B Large-cap | 0.71% | 10.43% | 20.23% | 39.34% | 39.43% | 30.27% | -4.28% | 3.03% |
Sanofi Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sanofi would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SAN's 52-week high and low?
- In the last 52 weeks, Sanofi reached a high of €110.88 (on March 10, 2025) and a low of €76.78 (on August 1, 2025).
- What is the market cap and P/E ratio for SAN?
- Curious about Sanofi's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does SAN pay dividends? If so, what's the yield?
- Yes, Sanofi is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 4.73%, and the company has paid an average of €3.75 per share annually over the past 3 years.
- Who are Sanofi's main competitors or similar companies to consider before investing?
When looking at Sanofi, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Virbac S.A
VIRP2.86B Healthcare Drug Manufacturers - General -0.29% -8.70% EssilorLuxottica
EL123.50B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.27B Healthcare Medical Instruments & Supplies -0.65% -53.41% bioMérieux S.A
BIM14.97B Healthcare Diagnostics & Research 23.21% 21.51% Eurofins Scientific
ERF11.97B Healthcare Diagnostics & Research 30.27% -4.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sanofi? (e.g., ROE, Debt/Equity)
- To get a sense of Sanofi's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for SAN?
- Looking at Sanofi's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of SAN stock is held by insiders and institutions?
- Wondering who owns Sanofi stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.